Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity ; volume:27 ; number:2 ; year:2020 ; pages:103-114
Portuguese journal of gastroenterology ; 27, Heft 2 (2020), 103-114
- Creator
-
Martins, Pedro
Verdelho Machado, Mariana
- DOI
-
10.1159/000501405
- URN
-
urn:nbn:de:101:1-2020030423022391140931
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martins, Pedro
- Verdelho Machado, Mariana
Other Objects (12)
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Biliary Cast Syndrome and Secondary Sclerosing Cholangitis in Critically Ill Patient after Long-Term Treatment in the Intensive Care Unit
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients
Bacterial cholangitis causing secondary sclerosing cholangitis: A case report
Secondary Sclerosing Cholangitis in critically-ill patients: Risikofaktoren, Diagnostik, Prognose und Therapie
Primary sclerosing cholangitis
COVID-19-associated secondary sclerosing cholangitis with liver transplantation
Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel
Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic
Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
Isolated variant of IgG4-sclerosing cholangitis masquerading as hilar cholangiocarcinoma — an enigmatic entity
Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients